

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transmembrane transport (GO:0006855) | 9.28059946 |
| 2 | urate metabolic process (GO:0046415) | 8.79593792 |
| 3 | drug transport (GO:0015893) | 8.21115332 |
| 4 | lipoprotein transport (GO:0042953) | 7.81367477 |
| 5 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.77194270 |
| 6 | drug catabolic process (GO:0042737) | 7.71106280 |
| 7 | lysine catabolic process (GO:0006554) | 7.13840971 |
| 8 | lysine metabolic process (GO:0006553) | 7.13840971 |
| 9 | organic cation transport (GO:0015695) | 7.02252917 |
| 10 | very-low-density lipoprotein particle assembly (GO:0034379) | 6.92019431 |
| 11 | regulation of triglyceride catabolic process (GO:0010896) | 6.86942126 |
| 12 | phosphate ion transport (GO:0006817) | 6.62078112 |
| 13 | plasma lipoprotein particle assembly (GO:0034377) | 6.59011105 |
| 14 | exogenous drug catabolic process (GO:0042738) | 6.58027613 |
| 15 | regulation of guanylate cyclase activity (GO:0031282) | 6.26575975 |
| 16 | epoxygenase P450 pathway (GO:0019373) | 6.18869617 |
| 17 | phospholipid efflux (GO:0033700) | 6.16537464 |
| 18 | cysteine metabolic process (GO:0006534) | 6.01664567 |
| 19 | protein-lipid complex assembly (GO:0065005) | 5.95035931 |
| 20 | intestinal absorption (GO:0050892) | 5.81400832 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.75158003 |
| 22 | modified amino acid transport (GO:0072337) | 5.68840104 |
| 23 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.67632985 |
| 24 | quaternary ammonium group transport (GO:0015697) | 5.67319839 |
| 25 | phosphate ion transmembrane transport (GO:0035435) | 5.61885640 |
| 26 | angiotensin maturation (GO:0002003) | 5.59436713 |
| 27 | nonribosomal peptide biosynthetic process (GO:0019184) | 5.55506073 |
| 28 | glyoxylate metabolic process (GO:0046487) | 5.55275522 |
| 29 | regulation of cholesterol esterification (GO:0010872) | 5.54709512 |
| 30 | renal absorption (GO:0070293) | 5.18880646 |
| 31 | glutathione biosynthetic process (GO:0006750) | 5.14047698 |
| 32 | excretion (GO:0007588) | 5.04392466 |
| 33 | peptide catabolic process (GO:0043171) | 5.00473029 |
| 34 | reverse cholesterol transport (GO:0043691) | 4.94947639 |
| 35 | tricarboxylic acid metabolic process (GO:0072350) | 4.87601021 |
| 36 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.80414765 |
| 37 | aspartate family amino acid catabolic process (GO:0009068) | 4.78827268 |
| 38 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.76240449 |
| 39 | endocrine process (GO:0050886) | 4.76240449 |
| 40 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.76240449 |
| 41 | response to mercury ion (GO:0046689) | 4.74438362 |
| 42 | oligosaccharide catabolic process (GO:0009313) | 4.73914725 |
| 43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.72759259 |
| 44 | vitamin D metabolic process (GO:0042359) | 4.70427850 |
| 45 | plasma lipoprotein particle remodeling (GO:0034369) | 4.67314313 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 4.67314313 |
| 47 | macromolecular complex remodeling (GO:0034367) | 4.67314313 |
| 48 | NADH metabolic process (GO:0006734) | 4.65427161 |
| 49 | flavonoid metabolic process (GO:0009812) | 4.65245012 |
| 50 | intestinal cholesterol absorption (GO:0030299) | 4.59181634 |
| 51 | response to phenylpropanoid (GO:0080184) | 4.56955088 |
| 52 | cholesterol efflux (GO:0033344) | 4.56594155 |
| 53 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.55713586 |
| 54 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.55713586 |
| 55 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.53223563 |
| 56 | homocysteine metabolic process (GO:0050667) | 4.52077706 |
| 57 | short-chain fatty acid metabolic process (GO:0046459) | 4.50295677 |
| 58 | trivalent inorganic anion homeostasis (GO:0072506) | 4.49733450 |
| 59 | phosphate ion homeostasis (GO:0055062) | 4.49733450 |
| 60 | fructose metabolic process (GO:0006000) | 4.49363329 |
| 61 | lipoprotein metabolic process (GO:0042157) | 4.47160630 |
| 62 | bile acid and bile salt transport (GO:0015721) | 4.42612419 |
| 63 | toxin transport (GO:1901998) | 4.38089275 |
| 64 | plasma lipoprotein particle organization (GO:0071827) | 4.31055204 |
| 65 | amino-acid betaine transport (GO:0015838) | 4.27277907 |
| 66 | carnitine transport (GO:0015879) | 4.27277907 |
| 67 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.23389636 |
| 68 | regulation of systemic arterial blood pressure (GO:0003073) | 4.23348717 |
| 69 | peptide biosynthetic process (GO:0043043) | 4.22580120 |
| 70 | proline metabolic process (GO:0006560) | 4.16596843 |
| 71 | protein-lipid complex subunit organization (GO:0071825) | 4.09975164 |
| 72 | cellular modified amino acid catabolic process (GO:0042219) | 4.04137638 |
| 73 | cellular glucuronidation (GO:0052695) | 4.04094762 |
| 74 | regulation of cGMP biosynthetic process (GO:0030826) | 4.03418194 |
| 75 | glucuronate metabolic process (GO:0019585) | 4.01120795 |
| 76 | uronic acid metabolic process (GO:0006063) | 4.01120795 |
| 77 | urea cycle (GO:0000050) | 3.99764089 |
| 78 | branched-chain amino acid metabolic process (GO:0009081) | 3.98235358 |
| 79 | amino-acid betaine metabolic process (GO:0006577) | 3.95288862 |
| 80 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.94809854 |
| 81 | cellular response to nitric oxide (GO:0071732) | 3.93714025 |
| 82 | peptide hormone processing (GO:0016486) | 3.93441288 |
| 83 | sulfur compound transport (GO:0072348) | 3.93400402 |
| 84 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.91338187 |
| 85 | drinking behavior (GO:0042756) | 3.90956219 |
| 86 | fatty acid beta-oxidation (GO:0006635) | 3.88851565 |
| 87 | L-phenylalanine metabolic process (GO:0006558) | 3.88266812 |
| 88 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.88266812 |
| 89 | serine family amino acid metabolic process (GO:0009069) | 3.86549812 |
| 90 | drug metabolic process (GO:0017144) | 3.84900264 |
| 91 | urea metabolic process (GO:0019627) | 3.84501558 |
| 92 | polyol transport (GO:0015791) | 3.81001480 |
| 93 | regulation of cellular extravasation (GO:0002691) | 3.80716902 |
| 94 | digestion (GO:0007586) | 3.79242893 |
| 95 | aromatic amino acid family catabolic process (GO:0009074) | 3.77097577 |
| 96 | sterol homeostasis (GO:0055092) | 3.76815409 |
| 97 | tryptophan catabolic process (GO:0006569) | 3.76484883 |
| 98 | indole-containing compound catabolic process (GO:0042436) | 3.76484883 |
| 99 | indolalkylamine catabolic process (GO:0046218) | 3.76484883 |
| 100 | 2-oxoglutarate metabolic process (GO:0006103) | 3.75994312 |
| 101 | beta-amyloid metabolic process (GO:0050435) | 3.75296289 |
| 102 | serine family amino acid catabolic process (GO:0009071) | 3.75128319 |
| 103 | vitamin transmembrane transport (GO:0035461) | 3.74883621 |
| 104 | metanephric nephron tubule development (GO:0072234) | 3.73516411 |
| 105 | metanephric tubule development (GO:0072170) | 3.73516411 |
| 106 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.72948364 |
| 107 | L-phenylalanine catabolic process (GO:0006559) | 3.72948364 |
| 108 | positive regulation of lipid catabolic process (GO:0050996) | 3.71951763 |
| 109 | glutathione metabolic process (GO:0006749) | 3.71586749 |
| 110 | cholesterol homeostasis (GO:0042632) | 3.71431337 |
| 111 | vitamin transport (GO:0051180) | 3.71266620 |
| 112 | carnitine metabolic process (GO:0009437) | 3.67908387 |
| 113 | glutathione derivative biosynthetic process (GO:1901687) | 3.67178678 |
| 114 | glutathione derivative metabolic process (GO:1901685) | 3.67178678 |
| 115 | glycoside metabolic process (GO:0016137) | 3.64020440 |
| 116 | hormone catabolic process (GO:0042447) | 3.61750798 |
| 117 | L-ascorbic acid metabolic process (GO:0019852) | 3.60187553 |
| 118 | valine metabolic process (GO:0006573) | 3.60155158 |
| 119 | nitrogen cycle metabolic process (GO:0071941) | 3.59574988 |
| 120 | tryptophan metabolic process (GO:0006568) | 3.59096223 |
| 121 | adhesion of symbiont to host (GO:0044406) | 3.58157746 |
| 122 | fatty acid oxidation (GO:0019395) | 3.57292841 |
| 123 | actin filament depolymerization (GO:0030042) | 3.54747240 |
| 124 | fat-soluble vitamin metabolic process (GO:0006775) | 3.53696010 |
| 125 | renal system process involved in regulation of blood volume (GO:0001977) | 3.53642008 |
| 126 | glutamate metabolic process (GO:0006536) | 3.52105605 |
| 127 | regulation of lipoprotein metabolic process (GO:0050746) | 3.50058124 |
| 128 | lipid oxidation (GO:0034440) | 3.50007813 |
| 129 | adhesion of symbiont to host cell (GO:0044650) | 3.48291023 |
| 130 | virion attachment to host cell (GO:0019062) | 3.48291023 |
| 131 | transepithelial transport (GO:0070633) | 3.48126740 |
| 132 | cellular carbohydrate catabolic process (GO:0044275) | 3.46140021 |
| 133 | alditol metabolic process (GO:0019400) | 3.43758826 |
| 134 | tricarboxylic acid cycle (GO:0006099) | 3.43748311 |
| 135 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.42345853 |
| 136 | negative regulation of sterol transport (GO:0032372) | 3.41990183 |
| 137 | negative regulation of cholesterol transport (GO:0032375) | 3.41990183 |
| 138 | glycerol metabolic process (GO:0006071) | 3.41848007 |
| 139 | metanephric nephron epithelium development (GO:0072243) | 3.41211195 |
| 140 | response to nitric oxide (GO:0071731) | 3.39827444 |
| 141 | serine family amino acid biosynthetic process (GO:0009070) | 3.38680747 |
| 142 | regulation of bile acid biosynthetic process (GO:0070857) | 3.37353112 |
| 143 | cellular ketone body metabolic process (GO:0046950) | 3.36360425 |
| 144 | fatty acid catabolic process (GO:0009062) | 3.36005625 |
| 145 | acetyl-CoA metabolic process (GO:0006084) | 3.34608862 |
| 146 | cellular response to reactive nitrogen species (GO:1902170) | 3.34266299 |
| 147 | regulation of cholesterol homeostasis (GO:2000188) | 3.32889103 |
| 148 | regulation of cGMP metabolic process (GO:0030823) | 3.32419057 |
| 149 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.26548555 |
| 150 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.26548555 |
| 151 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.25849715 |
| 152 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.25679255 |
| 153 | hydrogen peroxide catabolic process (GO:0042744) | 3.24628270 |
| 154 | vitamin biosynthetic process (GO:0009110) | 3.23180445 |
| 155 | glycolipid catabolic process (GO:0019377) | 3.19984275 |
| 156 | sulfate transmembrane transport (GO:1902358) | 3.19356517 |
| 157 | glycosylceramide metabolic process (GO:0006677) | 3.19255670 |
| 158 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.16498692 |
| 159 | digestive system process (GO:0022600) | 3.15975067 |
| 160 | glucose 6-phosphate metabolic process (GO:0051156) | 3.14701494 |
| 161 | glycosphingolipid catabolic process (GO:0046479) | 3.14595677 |
| 162 | branched-chain amino acid catabolic process (GO:0009083) | 3.14171608 |
| 163 | alkaloid metabolic process (GO:0009820) | 3.13970590 |
| 164 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.12787592 |
| 165 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.12175293 |
| 166 | diacylglycerol metabolic process (GO:0046339) | 3.11134415 |
| 167 | sexual reproduction (GO:0019953) | 3.10907069 |
| 168 | vitamin A metabolic process (GO:0006776) | 3.10675430 |
| 169 | regulation of vitamin metabolic process (GO:0030656) | 3.09700083 |
| 170 | bile acid metabolic process (GO:0008206) | 3.02234949 |
| 171 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.01699799 |
| 172 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.01476221 |
| 173 | low-density lipoprotein particle remodeling (GO:0034374) | 3.01168858 |
| 174 | mRNA modification (GO:0016556) | 3.00446678 |
| 175 | cobalamin metabolic process (GO:0009235) | 3.00133305 |
| 176 | arginine metabolic process (GO:0006525) | 2.99887200 |
| 177 | leukotriene metabolic process (GO:0006691) | 2.99870352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.78330889 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.70103061 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.35729901 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.97445479 |
| 5 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.95784016 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.81391736 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.77335024 |
| 8 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.61224516 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.99914075 |
| 10 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.78233376 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.71972339 |
| 12 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.61678977 |
| 13 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.56335659 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.54354448 |
| 15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.47702072 |
| 16 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.39393928 |
| 17 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.36248919 |
| 18 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.15462988 |
| 19 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.10057313 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.09736800 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.07765215 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.02936776 |
| 23 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.99073522 |
| 24 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.96217424 |
| 25 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.88200104 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.88057823 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.78760045 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.78720868 |
| 29 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.78074288 |
| 30 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.75798818 |
| 31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.75422976 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.72370329 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.69977852 |
| 34 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.69751615 |
| 35 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.69226153 |
| 36 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.56571260 |
| 37 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56267676 |
| 38 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.54348907 |
| 39 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.53850384 |
| 40 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.48231610 |
| 41 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.43785459 |
| 42 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.42466507 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.39011059 |
| 44 | VDR_22108803_ChIP-Seq_LS180_Human | 1.38847704 |
| 45 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.36211652 |
| 46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.35481069 |
| 47 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.30647662 |
| 48 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.22509790 |
| 49 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.20855452 |
| 50 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.19977884 |
| 51 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.17462686 |
| 52 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.16391656 |
| 53 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.15304778 |
| 54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13794360 |
| 55 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.12651080 |
| 56 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.11628822 |
| 57 | SA1_27219007_Chip-Seq_Bcells_Human | 1.09349392 |
| 58 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.08180015 |
| 59 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.06247823 |
| 60 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.05660935 |
| 61 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04800899 |
| 62 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04677996 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04440139 |
| 64 | GATA2_19941826_ChIP-Seq_K562_Human | 1.04434951 |
| 65 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.03119110 |
| 66 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01765226 |
| 67 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01068476 |
| 68 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.01012550 |
| 69 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.00882207 |
| 70 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00846901 |
| 71 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00758138 |
| 72 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.00677093 |
| 73 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.99703374 |
| 74 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.99665964 |
| 75 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.96127596 |
| 76 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.96020125 |
| 77 | ATF3_27146783_Chip-Seq_COLON_Human | 0.95106443 |
| 78 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95041863 |
| 79 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.94878960 |
| 80 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.94703970 |
| 81 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.93964329 |
| 82 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.93011054 |
| 83 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92736594 |
| 84 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.92129372 |
| 85 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90662138 |
| 86 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89851885 |
| 87 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.88949522 |
| 88 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88487125 |
| 89 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.88474247 |
| 90 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.87603820 |
| 91 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.87222432 |
| 92 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.86460729 |
| 93 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.85740941 |
| 94 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.84608994 |
| 95 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.83859245 |
| 96 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83557285 |
| 97 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.82985108 |
| 98 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82776838 |
| 99 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.81675351 |
| 100 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81630725 |
| 101 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.81205864 |
| 102 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80686472 |
| 103 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.80453792 |
| 104 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.79546499 |
| 105 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.79271237 |
| 106 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78598716 |
| 107 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78444753 |
| 108 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.77862278 |
| 109 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.77248868 |
| 110 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.77173832 |
| 111 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.76787372 |
| 112 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.76430582 |
| 113 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.76030362 |
| 114 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.75367747 |
| 115 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.74011939 |
| 116 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.73901015 |
| 117 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.73873608 |
| 118 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.73733282 |
| 119 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.73733282 |
| 120 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.73319978 |
| 121 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72779698 |
| 122 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.72215534 |
| 123 | P68_20966046_ChIP-Seq_HELA_Human | 0.72161208 |
| 124 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.71710216 |
| 125 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71442559 |
| 126 | RXR_22108803_ChIP-Seq_LS180_Human | 0.71045214 |
| 127 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.69900175 |
| 128 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.69763818 |
| 129 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69389359 |
| 130 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.69162789 |
| 131 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.69093975 |
| 132 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.68746055 |
| 133 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.68656127 |
| 134 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.68399902 |
| 135 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.67601795 |
| 136 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.66475293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 9.90537792 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.31882804 |
| 3 | MP0004043_abnormal_pH_regulation | 5.21855695 |
| 4 | MP0004019_abnormal_vitamin_homeostasis | 4.56789388 |
| 5 | MP0005332_abnormal_amino_acid | 4.16915410 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.43064014 |
| 7 | MP0001666_abnormal_nutrient_absorption | 3.38438412 |
| 8 | MP0009643_abnormal_urine_homeostasis | 3.31784893 |
| 9 | MP0003252_abnormal_bile_duct | 3.03631364 |
| 10 | MP0001765_abnormal_ion_homeostasis | 3.02040453 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.92926549 |
| 12 | MP0009379_abnormal_foot_pigmentation | 2.81198374 |
| 13 | MP0003878_abnormal_ear_physiology | 2.76879994 |
| 14 | MP0005377_hearing/vestibular/ear_phenot | 2.76879994 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.71477474 |
| 16 | MP0005636_abnormal_mineral_homeostasis | 2.54458143 |
| 17 | MP0003195_calcinosis | 2.50103307 |
| 18 | MP0005365_abnormal_bile_salt | 2.42720852 |
| 19 | MP0002136_abnormal_kidney_physiology | 2.37465378 |
| 20 | MP0001756_abnormal_urination | 2.34021378 |
| 21 | MP0004264_abnormal_extraembryonic_tissu | 2.00473665 |
| 22 | MP0005409_darkened_coat_color | 2.00038109 |
| 23 | MP0005084_abnormal_gallbladder_morpholo | 1.98953295 |
| 24 | MP0009840_abnormal_foam_cell | 1.97869948 |
| 25 | MP0004270_analgesia | 1.93467989 |
| 26 | MP0000538_abnormal_urinary_bladder | 1.87308232 |
| 27 | MP0010234_abnormal_vibrissa_follicle | 1.78689020 |
| 28 | MP0004147_increased_porphyrin_level | 1.73192383 |
| 29 | MP0010329_abnormal_lipoprotein_level | 1.70364495 |
| 30 | MP0003868_abnormal_feces_composition | 1.60151843 |
| 31 | MP0003183_abnormal_peptide_metabolism | 1.59572615 |
| 32 | MP0001958_emphysema | 1.57332462 |
| 33 | MP0002876_abnormal_thyroid_physiology | 1.49486715 |
| 34 | MP0003718_maternal_effect | 1.47450262 |
| 35 | MP0003806_abnormal_nucleotide_metabolis | 1.47210751 |
| 36 | MP0005058_abnormal_lysosome_morphology | 1.45242350 |
| 37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.41671487 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.31250357 |
| 39 | MP0008961_abnormal_basal_metabolism | 1.29380279 |
| 40 | MP0002089_abnormal_postnatal_growth/wei | 1.29092655 |
| 41 | MP0005319_abnormal_enzyme/_coenzyme | 1.28627891 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.27926230 |
| 43 | MP0010352_gastrointestinal_tract_polyps | 1.27630972 |
| 44 | MP0004782_abnormal_surfactant_physiolog | 1.24843093 |
| 45 | MP0004885_abnormal_endolymph | 1.24534908 |
| 46 | MP0005451_abnormal_body_composition | 1.17510323 |
| 47 | MP0001764_abnormal_homeostasis | 1.15204128 |
| 48 | MP0001188_hyperpigmentation | 1.14170143 |
| 49 | MP0000490_abnormal_crypts_of | 1.12351196 |
| 50 | MP0002118_abnormal_lipid_homeostasis | 1.10282350 |
| 51 | MP0003186_abnormal_redox_activity | 1.10161299 |
| 52 | MP0001501_abnormal_sleep_pattern | 1.04808495 |
| 53 | MP0003866_abnormal_defecation | 1.04688979 |
| 54 | MP0006036_abnormal_mitochondrial_physio | 1.02088444 |
| 55 | MP0000230_abnormal_systemic_arterial | 0.99478236 |
| 56 | MP0002796_impaired_skin_barrier | 0.96921168 |
| 57 | MP0003283_abnormal_digestive_organ | 0.87747484 |
| 58 | MP0000609_abnormal_liver_physiology | 0.87162873 |
| 59 | MP0003638_abnormal_response/metabolism_ | 0.85870393 |
| 60 | MP0000462_abnormal_digestive_system | 0.85850296 |
| 61 | MP0004858_abnormal_nervous_system | 0.84386132 |
| 62 | MP0001663_abnormal_digestive_system | 0.83987794 |
| 63 | MP0005535_abnormal_body_temperature | 0.82944487 |
| 64 | MP0009115_abnormal_fat_cell | 0.82260492 |
| 65 | MP0002135_abnormal_kidney_morphology | 0.79877278 |
| 66 | MP0009642_abnormal_blood_homeostasis | 0.78303402 |
| 67 | MP0001664_abnormal_digestion | 0.78240796 |
| 68 | MP0003879_abnormal_hair_cell | 0.77965548 |
| 69 | MP0006138_congestive_heart_failure | 0.76713882 |
| 70 | MP0000249_abnormal_blood_vessel | 0.75299206 |
| 71 | MP0005381_digestive/alimentary_phenotyp | 0.74189219 |
| 72 | MP0005666_abnormal_adipose_tissue | 0.68706854 |
| 73 | MP0002928_abnormal_bile_duct | 0.67016817 |
| 74 | MP0005501_abnormal_skin_physiology | 0.66887753 |
| 75 | MP0002896_abnormal_bone_mineralization | 0.65410673 |
| 76 | MP0001845_abnormal_inflammatory_respons | 0.63382580 |
| 77 | MP0003705_abnormal_hypodermis_morpholog | 0.62092391 |
| 78 | MP0009764_decreased_sensitivity_to | 0.60518733 |
| 79 | MP0005334_abnormal_fat_pad | 0.60497004 |
| 80 | MP0002822_catalepsy | 0.58963679 |
| 81 | MP0009780_abnormal_chondrocyte_physiolo | 0.58744521 |
| 82 | MP0002168_other_aberrant_phenotype | 0.58233847 |
| 83 | MP0002098_abnormal_vibrissa_morphology | 0.56274340 |
| 84 | MP0008260_abnormal_autophagy | 0.55989725 |
| 85 | MP0004484_altered_response_of | 0.54927997 |
| 86 | MP0000678_abnormal_parathyroid_gland | 0.54260585 |
| 87 | MP0005083_abnormal_biliary_tract | 0.52972357 |
| 88 | MP0000477_abnormal_intestine_morphology | 0.51856513 |
| 89 | MP0001485_abnormal_pinna_reflex | 0.51593735 |
| 90 | MP0003724_increased_susceptibility_to | 0.51491537 |
| 91 | MP0000598_abnormal_liver_morphology | 0.51422125 |
| 92 | MP0005167_abnormal_blood-brain_barrier | 0.51152386 |
| 93 | MP0008469_abnormal_protein_level | 0.50853453 |
| 94 | MP0002078_abnormal_glucose_homeostasis | 0.50349747 |
| 95 | MP0000537_abnormal_urethra_morphology | 0.48762216 |
| 96 | MP0006082_CNS_inflammation | 0.48206774 |
| 97 | MP0005395_other_phenotype | 0.45860581 |
| 98 | MP0005448_abnormal_energy_balance | 0.45572616 |
| 99 | MP0010155_abnormal_intestine_physiology | 0.45430101 |
| 100 | MP0005266_abnormal_metabolism | 0.45276001 |
| 101 | MP0005670_abnormal_white_adipose | 0.45103867 |
| 102 | MP0003646_muscle_fatigue | 0.45096948 |
| 103 | MP0003953_abnormal_hormone_level | 0.44504113 |
| 104 | MP0000566_synostosis | 0.44345772 |
| 105 | MP0008872_abnormal_physiological_respon | 0.44318079 |
| 106 | MP0005376_homeostasis/metabolism_phenot | 0.43418381 |
| 107 | MP0009785_altered_susceptibility_to | 0.41763695 |
| 108 | MP0006054_spinal_hemorrhage | 0.40843109 |
| 109 | MP0003329_amyloid_beta_deposits | 0.39731994 |
| 110 | MP0000371_diluted_coat_color | 0.39249207 |
| 111 | MP0005166_decreased_susceptibility_to | 0.38058382 |
| 112 | MP0003959_abnormal_lean_body | 0.37835093 |
| 113 | MP0009765_abnormal_xenobiotic_induced | 0.37768202 |
| 114 | MP0001873_stomach_inflammation | 0.37477405 |
| 115 | MP0002734_abnormal_mechanical_nocicepti | 0.36578563 |
| 116 | MP0006035_abnormal_mitochondrial_morpho | 0.36563560 |
| 117 | MP0003315_abnormal_perineum_morphology | 0.36302875 |
| 118 | MP0010386_abnormal_urinary_bladder | 0.36302278 |
| 119 | MP0005165_increased_susceptibility_to | 0.36286191 |
| 120 | MP0005408_hypopigmentation | 0.35419457 |
| 121 | MP0002069_abnormal_eating/drinking_beha | 0.35117000 |
| 122 | MP0005375_adipose_tissue_phenotype | 0.35040426 |
| 123 | MP0005330_cardiomyopathy | 0.34051056 |
| 124 | MP0002971_abnormal_brown_adipose | 0.33537309 |
| 125 | MP0000427_abnormal_hair_cycle | 0.32335817 |
| 126 | MP0005025_abnormal_response_to | 0.32326142 |
| 127 | MP0000747_muscle_weakness | 0.32273109 |
| 128 | MP0005645_abnormal_hypothalamus_physiol | 0.31635400 |
| 129 | MP0002396_abnormal_hematopoietic_system | 0.31417420 |
| 130 | MP0000604_amyloidosis | 0.31041899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 6.39020577 |
| 2 | Metabolic alkalosis (HP:0200114) | 6.36401121 |
| 3 | Gout (HP:0001997) | 6.27586186 |
| 4 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 6.14294653 |
| 5 | Hyperactive renin-angiotensin system (HP:0000841) | 6.05199927 |
| 6 | Hypokalemic alkalosis (HP:0001949) | 6.00582960 |
| 7 | Hypomagnesemia (HP:0002917) | 5.77093109 |
| 8 | Abnormality of chloride homeostasis (HP:0011422) | 5.63465956 |
| 9 | Abnormal urine output (HP:0012590) | 5.58993711 |
| 10 | Polyuria (HP:0000103) | 5.51882173 |
| 11 | Abnormality of renal excretion (HP:0011036) | 5.33085924 |
| 12 | Proximal tubulopathy (HP:0000114) | 5.28433648 |
| 13 | Abnormality of magnesium homeostasis (HP:0004921) | 5.17016981 |
| 14 | Hyperglycinuria (HP:0003108) | 5.16930768 |
| 15 | Hyperuricemia (HP:0002149) | 4.80980688 |
| 16 | Increased purine levels (HP:0004368) | 4.80980688 |
| 17 | Abnormality of purine metabolism (HP:0004352) | 4.72830531 |
| 18 | Pigmentary retinal degeneration (HP:0001146) | 4.61284933 |
| 19 | Chronic diarrhea (HP:0002028) | 4.53600833 |
| 20 | Abnormal drinking behavior (HP:0030082) | 4.38084277 |
| 21 | Polydipsia (HP:0001959) | 4.38084277 |
| 22 | Glycosuria (HP:0003076) | 4.21062953 |
| 23 | Abnormality of urine glucose concentration (HP:0011016) | 4.21062953 |
| 24 | Hypolipoproteinemia (HP:0010981) | 4.19886269 |
| 25 | Alkalosis (HP:0001948) | 4.16131032 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.13792584 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 4.13792584 |
| 28 | Abnormality of proline metabolism (HP:0010907) | 4.13394639 |
| 29 | Hydroxyprolinuria (HP:0003080) | 4.13394639 |
| 30 | Abnormality of renin-angiotensin system (HP:0000847) | 4.10877534 |
| 31 | Hyperaldosteronism (HP:0000859) | 4.00050571 |
| 32 | Tetany (HP:0001281) | 3.97559822 |
| 33 | Generalized aminoaciduria (HP:0002909) | 3.87802952 |
| 34 | Hypercalciuria (HP:0002150) | 3.86456038 |
| 35 | Renal salt wasting (HP:0000127) | 3.83977090 |
| 36 | Systemic lupus erythematosus (HP:0002725) | 3.80515985 |
| 37 | Abnormality of vitamin metabolism (HP:0100508) | 3.69888942 |
| 38 | Ketoacidosis (HP:0001993) | 3.69183201 |
| 39 | Hyperphosphaturia (HP:0003109) | 3.58763942 |
| 40 | Malnutrition (HP:0004395) | 3.57956519 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 3.53257306 |
| 42 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.42642076 |
| 43 | Posterior subcapsular cataract (HP:0007787) | 3.35530766 |
| 44 | Congenital sensorineural hearing impairment (HP:0008527) | 3.32305541 |
| 45 | Abnormal urine phosphate concentration (HP:0012599) | 3.30457625 |
| 46 | Nephrolithiasis (HP:0000787) | 3.29309338 |
| 47 | Renal tubular acidosis (HP:0001947) | 3.28428534 |
| 48 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.25050838 |
| 49 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.19418540 |
| 50 | Widely patent fontanelles and sutures (HP:0004492) | 3.17489025 |
| 51 | Hypokalemia (HP:0002900) | 3.14598491 |
| 52 | Ketosis (HP:0001946) | 3.12264826 |
| 53 | Delayed epiphyseal ossification (HP:0002663) | 3.05382944 |
| 54 | Ileus (HP:0002595) | 2.97538134 |
| 55 | Dehydration (HP:0001944) | 2.93625748 |
| 56 | Steatorrhea (HP:0002570) | 2.89155848 |
| 57 | Hyperlipoproteinemia (HP:0010980) | 2.88192233 |
| 58 | Hypophosphatemia (HP:0002148) | 2.84681385 |
| 59 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.78044182 |
| 60 | Metabolic acidosis (HP:0001942) | 2.74840346 |
| 61 | Subcapsular cataract (HP:0000523) | 2.70913617 |
| 62 | Confusion (HP:0001289) | 2.69102703 |
| 63 | Epidermoid cyst (HP:0200040) | 2.67678036 |
| 64 | Hyperammonemia (HP:0001987) | 2.63895697 |
| 65 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.63318147 |
| 66 | Abnormality of potassium homeostasis (HP:0011042) | 2.61280554 |
| 67 | Vascular calcification (HP:0004934) | 2.59989390 |
| 68 | Nephrocalcinosis (HP:0000121) | 2.59752012 |
| 69 | Facial shape deformation (HP:0011334) | 2.55242663 |
| 70 | Potter facies (HP:0002009) | 2.55242663 |
| 71 | Decreased circulating renin level (HP:0003351) | 2.52336244 |
| 72 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.49779580 |
| 73 | Metaphyseal cupping (HP:0003021) | 2.44780844 |
| 74 | Hemorrhage of the eye (HP:0011885) | 2.44540075 |
| 75 | Hyperglycinemia (HP:0002154) | 2.43752119 |
| 76 | Rickets (HP:0002748) | 2.42736027 |
| 77 | Abdominal distention (HP:0003270) | 2.42553397 |
| 78 | Delayed CNS myelination (HP:0002188) | 2.39912424 |
| 79 | Autoimmune thrombocytopenia (HP:0001973) | 2.39105518 |
| 80 | Poikilocytosis (HP:0004447) | 2.38695353 |
| 81 | Dicarboxylic aciduria (HP:0003215) | 2.37844970 |
| 82 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.37844970 |
| 83 | Enlarged epiphyses (HP:0010580) | 2.36784874 |
| 84 | Vacuolated lymphocytes (HP:0001922) | 2.33685416 |
| 85 | Vomiting (HP:0002013) | 2.31316391 |
| 86 | Cardiovascular calcification (HP:0011915) | 2.30214905 |
| 87 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.29789604 |
| 88 | Thin bony cortex (HP:0002753) | 2.24198316 |
| 89 | Focal segmental glomerulosclerosis (HP:0000097) | 2.23539465 |
| 90 | Nausea (HP:0002018) | 2.22738728 |
| 91 | Abnormal tarsal ossification (HP:0008369) | 2.21017257 |
| 92 | Sensorimotor neuropathy (HP:0007141) | 2.20823189 |
| 93 | Xanthomatosis (HP:0000991) | 2.18063461 |
| 94 | Abnormal glucose tolerance (HP:0001952) | 2.15358549 |
| 95 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.12669814 |
| 96 | Abnormality of vitamin B metabolism (HP:0004340) | 2.12606535 |
| 97 | Pancreatitis (HP:0001733) | 2.09466854 |
| 98 | Lethargy (HP:0001254) | 2.07872433 |
| 99 | Renal tubular dysfunction (HP:0000124) | 2.06393462 |
| 100 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.06259509 |
| 101 | Hyponatremia (HP:0002902) | 2.04582705 |
| 102 | Abnormality of sodium homeostasis (HP:0010931) | 2.04087437 |
| 103 | Complement deficiency (HP:0004431) | 2.02832583 |
| 104 | Hyperphosphatemia (HP:0002905) | 2.02133932 |
| 105 | Glomerulonephritis (HP:0000099) | 1.99974444 |
| 106 | Methylmalonic aciduria (HP:0012120) | 1.99658183 |
| 107 | Hyperparathyroidism (HP:0000843) | 1.98707042 |
| 108 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.96855528 |
| 109 | Eczematoid dermatitis (HP:0000976) | 1.96494765 |
| 110 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.94320809 |
| 111 | Enlarged kidneys (HP:0000105) | 1.91679890 |
| 112 | Abnormality of renal resorption (HP:0011038) | 1.89909197 |
| 113 | Adrenal overactivity (HP:0002717) | 1.89818297 |
| 114 | Wide cranial sutures (HP:0010537) | 1.89368104 |
| 115 | Abnormality of complement system (HP:0005339) | 1.87176590 |
| 116 | Cerebral palsy (HP:0100021) | 1.86132610 |
| 117 | Hypobetalipoproteinemia (HP:0003563) | 1.85788266 |
| 118 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.84825728 |
| 119 | Villous atrophy (HP:0011473) | 1.84825728 |
| 120 | Fat malabsorption (HP:0002630) | 1.83582859 |
| 121 | Late onset (HP:0003584) | 1.81588641 |
| 122 | Irritability (HP:0000737) | 1.81417588 |
| 123 | Conjugated hyperbilirubinemia (HP:0002908) | 1.80478480 |
| 124 | Amyloidosis (HP:0011034) | 1.78558262 |
| 125 | Gastrointestinal dysmotility (HP:0002579) | 1.78520268 |
| 126 | Hypophosphatemic rickets (HP:0004912) | 1.78473151 |
| 127 | Megaloblastic anemia (HP:0001889) | 1.77633474 |
| 128 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.76535456 |
| 129 | Growth hormone excess (HP:0000845) | 1.75026319 |
| 130 | Hypotension (HP:0002615) | 1.74884264 |
| 131 | Acanthocytosis (HP:0001927) | 1.72826372 |
| 132 | Abnormality of the costochondral junction (HP:0000919) | 1.71356638 |
| 133 | Abnormality of carpal bone ossification (HP:0006257) | 1.70575365 |
| 134 | Nephritis (HP:0000123) | 1.70567952 |
| 135 | Peripheral demyelination (HP:0011096) | 1.70491595 |
| 136 | Glomerulosclerosis (HP:0000096) | 1.70326873 |
| 137 | White forelock (HP:0002211) | 1.69561840 |
| 138 | Chondrocalcinosis (HP:0000934) | 1.69121196 |
| 139 | Protuberant abdomen (HP:0001538) | 1.67523684 |
| 140 | Intrahepatic cholestasis (HP:0001406) | 1.67111043 |
| 141 | Abnormality of macrophages (HP:0004311) | 1.63888375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 8.02581630 |
| 2 | ACVR1B | 7.82361957 |
| 3 | WNK3 | 6.64695756 |
| 4 | OXSR1 | 6.37455477 |
| 5 | STK39 | 3.73542733 |
| 6 | PIK3CG | 3.64372352 |
| 7 | MST4 | 3.40753617 |
| 8 | MUSK | 2.97748065 |
| 9 | MST1R | 2.69384392 |
| 10 | FRK | 2.63393626 |
| 11 | BCKDK | 2.58306389 |
| 12 | GRK6 | 2.27632711 |
| 13 | STK38L | 2.24939998 |
| 14 | PDK3 | 2.12056074 |
| 15 | PDK4 | 2.12056074 |
| 16 | NEK1 | 2.09758425 |
| 17 | MAP4K2 | 2.03546461 |
| 18 | TNIK | 1.93838726 |
| 19 | PDK2 | 1.68848192 |
| 20 | WNK1 | 1.64848351 |
| 21 | LMTK2 | 1.59781643 |
| 22 | SGK223 | 1.49086549 |
| 23 | SGK494 | 1.49086549 |
| 24 | NME1 | 1.48873767 |
| 25 | EPHA3 | 1.33165416 |
| 26 | GRK1 | 1.25695083 |
| 27 | PRKG2 | 1.20694608 |
| 28 | MAP3K12 | 1.19470792 |
| 29 | CDC42BPA | 1.18645611 |
| 30 | STK24 | 1.17727043 |
| 31 | RIPK1 | 1.17467318 |
| 32 | EPHA4 | 1.16500948 |
| 33 | ERN1 | 1.15685158 |
| 34 | PTK6 | 1.14728851 |
| 35 | STK38 | 1.08646475 |
| 36 | TYK2 | 1.08251266 |
| 37 | LRRK2 | 1.03088872 |
| 38 | FGFR3 | 1.03063884 |
| 39 | NLK | 1.01618900 |
| 40 | MAP3K2 | 0.99154392 |
| 41 | MAP4K1 | 0.99099505 |
| 42 | EPHB1 | 0.96355505 |
| 43 | PIK3CA | 0.95045127 |
| 44 | SGK3 | 0.87826675 |
| 45 | FGFR4 | 0.85837614 |
| 46 | STK10 | 0.85362044 |
| 47 | MET | 0.84965814 |
| 48 | MAP3K7 | 0.84881188 |
| 49 | PTK2 | 0.82532386 |
| 50 | EPHA2 | 0.82047788 |
| 51 | PRKCI | 0.79215028 |
| 52 | MAP3K10 | 0.78580354 |
| 53 | MAP2K2 | 0.76359598 |
| 54 | MAP3K3 | 0.73603626 |
| 55 | GSK3A | 0.71699425 |
| 56 | PAK4 | 0.71593254 |
| 57 | AKT3 | 0.71140608 |
| 58 | SGK2 | 0.67030651 |
| 59 | CASK | 0.66410171 |
| 60 | DYRK1B | 0.65858761 |
| 61 | PDGFRA | 0.64004458 |
| 62 | DMPK | 0.63486783 |
| 63 | MAPK11 | 0.61124840 |
| 64 | PRKAA2 | 0.60858353 |
| 65 | PDPK1 | 0.60794354 |
| 66 | PINK1 | 0.59585224 |
| 67 | EPHB2 | 0.58256249 |
| 68 | FER | 0.58255256 |
| 69 | PRKAA1 | 0.57499204 |
| 70 | RET | 0.54396463 |
| 71 | IRAK1 | 0.54277433 |
| 72 | MYLK | 0.53356494 |
| 73 | PRPF4B | 0.49690121 |
| 74 | CSF1R | 0.47964730 |
| 75 | CAMK2D | 0.46881026 |
| 76 | BMX | 0.46822471 |
| 77 | MAP3K11 | 0.45934330 |
| 78 | SGK1 | 0.43290161 |
| 79 | CAMK2G | 0.42481019 |
| 80 | PAK3 | 0.41551921 |
| 81 | LATS1 | 0.39576931 |
| 82 | ITK | 0.39133489 |
| 83 | CAMK2B | 0.38828061 |
| 84 | TAOK1 | 0.38796123 |
| 85 | PDK1 | 0.37579137 |
| 86 | MAP2K6 | 0.35782816 |
| 87 | ABL2 | 0.35253545 |
| 88 | ERBB4 | 0.34799788 |
| 89 | TESK2 | 0.34551804 |
| 90 | CAMK2A | 0.34036311 |
| 91 | TESK1 | 0.33399390 |
| 92 | SCYL2 | 0.31806728 |
| 93 | RPS6KA2 | 0.31273751 |
| 94 | IRAK3 | 0.31124131 |
| 95 | FYN | 0.30314063 |
| 96 | PRKCZ | 0.30201238 |
| 97 | PRKCD | 0.29031140 |
| 98 | DDR2 | 0.28813793 |
| 99 | KIT | 0.27983576 |
| 100 | TTK | 0.27784214 |
| 101 | MAP3K8 | 0.27199746 |
| 102 | STK11 | 0.27034955 |
| 103 | INSRR | 0.26123514 |
| 104 | MATK | 0.25820054 |
| 105 | ICK | 0.25172271 |
| 106 | SYK | 0.25084150 |
| 107 | KDR | 0.25056748 |
| 108 | AKT2 | 0.24903840 |
| 109 | PIM2 | 0.24310765 |
| 110 | PRKACG | 0.24309197 |
| 111 | LCK | 0.24024390 |
| 112 | PRKCA | 0.23855201 |
| 113 | CDK19 | 0.23535802 |
| 114 | NEK6 | 0.23241794 |
| 115 | GRK5 | 0.23235565 |
| 116 | OBSCN | 0.22989515 |
| 117 | TAOK3 | 0.22967552 |
| 118 | ADRBK2 | 0.22065865 |
| 119 | TIE1 | 0.21273980 |
| 120 | NUAK1 | 0.16925311 |
| 121 | MAP2K1 | 0.16647363 |
| 122 | TRIB3 | 0.16457657 |
| 123 | KSR2 | 0.16005260 |
| 124 | PTK2B | 0.15798093 |
| 125 | TGFBR2 | 0.14116678 |
| 126 | PIM1 | 0.12885652 |
| 127 | ERBB2 | 0.12699235 |
| 128 | ROCK1 | 0.12445869 |
| 129 | TBK1 | 0.11915455 |
| 130 | SRC | 0.11851167 |
| 131 | MAPK15 | 0.11115935 |
| 132 | PRKCQ | 0.10532490 |
| 133 | RIPK4 | 0.10433708 |
| 134 | CSK | 0.10273199 |
| 135 | PRKD2 | 0.09760663 |
| 136 | MAP3K14 | 0.09468401 |
| 137 | JAK2 | 0.09430229 |
| 138 | MAP3K1 | 0.08931427 |
| 139 | PRKACA | 0.08502251 |
| 140 | CSNK1A1 | 0.07505370 |
| 141 | MAP2K4 | 0.06646908 |
| 142 | INSR | 0.05126801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.58449565 |
| 2 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.32239990 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.19004079 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.08024739 |
| 5 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.94766700 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.66610387 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61702824 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.58695313 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.51382092 |
| 10 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.46596645 |
| 11 | Mineral absorption_Homo sapiens_hsa04978 | 2.44458359 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.43159973 |
| 13 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.37626619 |
| 14 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.36196819 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.30979954 |
| 16 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.19979383 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.12991294 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.10831544 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 2.05496363 |
| 20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.05452787 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.99595033 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.99246741 |
| 23 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.88325154 |
| 24 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.79383448 |
| 25 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.78376236 |
| 26 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.76567338 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65772067 |
| 28 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.63306412 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.57615553 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.51618063 |
| 31 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.51515736 |
| 32 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.50521653 |
| 33 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.49059232 |
| 34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.46454659 |
| 35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.43394011 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.43286039 |
| 37 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.42348598 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.41227178 |
| 39 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.39887222 |
| 40 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.38781589 |
| 41 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.29511537 |
| 42 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.25528968 |
| 43 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.24184107 |
| 44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.23955482 |
| 45 | Galactose metabolism_Homo sapiens_hsa00052 | 1.23178814 |
| 46 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.20886207 |
| 47 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.15265674 |
| 48 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.14338911 |
| 49 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.07100353 |
| 50 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.06063449 |
| 51 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.05745426 |
| 52 | Lysine degradation_Homo sapiens_hsa00310 | 1.01215772 |
| 53 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.94400430 |
| 54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.94267632 |
| 55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.91205397 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88389132 |
| 57 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.86476935 |
| 58 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.82225928 |
| 59 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77164910 |
| 60 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.73781207 |
| 61 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.72309984 |
| 62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.70321152 |
| 63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69274584 |
| 64 | Asthma_Homo sapiens_hsa05310 | 0.64681398 |
| 65 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64380663 |
| 66 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.63101844 |
| 67 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.61876353 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59068471 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58135436 |
| 70 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.57009544 |
| 71 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.55534846 |
| 72 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.52795205 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51745920 |
| 74 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.50220150 |
| 75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.49500619 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.49047676 |
| 77 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.46488706 |
| 78 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.45549590 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.42951332 |
| 80 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42632786 |
| 81 | Renin secretion_Homo sapiens_hsa04924 | 0.42266721 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38576865 |
| 83 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.37635934 |
| 84 | Allograft rejection_Homo sapiens_hsa05330 | 0.36295526 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33853721 |
| 86 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.33252602 |
| 87 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.32821053 |
| 88 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32455566 |
| 89 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.32085835 |
| 90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.27793399 |
| 91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.27412517 |
| 92 | Parkinsons disease_Homo sapiens_hsa05012 | 0.27248705 |
| 93 | Lysosome_Homo sapiens_hsa04142 | 0.25853848 |
| 94 | Cocaine addiction_Homo sapiens_hsa05030 | 0.24837827 |
| 95 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.22570963 |
| 96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.17170661 |
| 97 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.17130478 |
| 98 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.16037892 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.14719572 |
| 100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.14530413 |
| 101 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.14205939 |
| 102 | Sulfur relay system_Homo sapiens_hsa04122 | 0.12989157 |
| 103 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.12030861 |
| 104 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.11242193 |
| 105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.10342331 |
| 106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.10263413 |
| 107 | Alzheimers disease_Homo sapiens_hsa05010 | 0.08240868 |
| 108 | Insulin secretion_Homo sapiens_hsa04911 | 0.07813463 |
| 109 | Tight junction_Homo sapiens_hsa04530 | 0.07392230 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.06478941 |
| 111 | Pertussis_Homo sapiens_hsa05133 | 0.05894880 |
| 112 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.05631122 |
| 113 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.05260114 |
| 114 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.05065270 |
| 115 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.04812918 |
| 116 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.04639274 |
| 117 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.04458959 |
| 118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.04365005 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.04361442 |
| 120 | Salivary secretion_Homo sapiens_hsa04970 | 0.03777144 |
| 121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.02874970 |
| 122 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.02363001 |
| 123 | Hepatitis C_Homo sapiens_hsa05160 | -0.0207378 |
| 124 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | -0.0136477 |
| 125 | Bladder cancer_Homo sapiens_hsa05219 | -0.0074573 |
| 126 | Cardiac muscle contraction_Homo sapiens_hsa04260 | -0.0073051 |
| 127 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0033180 |

